Chinese Surgeons Trained in use of HyProCure® at 2012 TongRen Foot and Ankle Symposium

Oct. 3, 2012 - PRLog -- Beijing, China – The 2012 TongRen Foot and Ankle Symposium, held in Beijing, China, September 14-16, at the Beijing Radegast Lake View Hotel, was host to over 300 orthopedic foot surgeons, the elite foot surgeons of China.

Michael E. Graham, DPM, FACFAS, FAENS, founder of GraMedica^® and creator of HyProCure^®, presented several lectures during the symposium. Topics included “Pes Planovalgus vs. Talotarsal Displacement,” “Orthotics for Flatfoot,” “Classification of Extra-Osseous TaloTarsal Stabilization Devices” and “The HyProCure^® Surgical Technique.”

In addition to various lectures on EOTTS, a cadaver workshop, the first foot cadaver course ever held in China, was hosted to demonstrate the procedure and provide hands-on experience. Approximately 150 specialists were invited to attend. “The room was packed with surgeons, all with their cameras and video cameras, eager for their first foot cadaver course,” said Graham. “It was amazing to be involved in such a ground-breaking event.”

Foot and ankle surgery is an emerging orthopedic specialty in China with a rapidly growing awareness and interest. Chinese physicians were first introduced to HyProCure^® at the Sixth International Congress of (the) Chinese Orthopaedic Association (COA) in Beijing, China, December 1 – 4, 2011. Several prominent foot and ankle specialists were impressed by the possibilities HyProCure^® offered to help patents improve their quality of life and plans were put in motion to select patients. HyProCure^® received SFDA approval (Chinese version of FDA) in 2011. The first EOTTS procedures in China were performed in April of 2012.

The 2012 symposium was a successful educational feat for orthopedic foot surgeons in China. Lectures were also given by Dr. Łukasz Kołodziej of Poland and Dr. Jian Zhong Zhang, M.D., Prof., Director of Foot and Ankle Services, Chief of the Department of Orthopaedics at Beijing Tongren Hospital and Capital Medical University. Dr. Zhang is the leading foot and ankle specialist in all of China and has been working hard to build a greater awareness for the importance of treating foot and ankle pathologies.

The HyProCure^® device, offered by GraMedica^®, a global orthopedic medical device company, is a breakthrough treatment option for partial talotarsal dislocation, a condition affecting of people of all ages throughout the world. When talotarsal displacement occurs, it creates a damaging misalignment of forces both in the foot itself, as well as throughout the entire body. Via a minimally invasive procedure, HyProCure^® instantly corrects the problem at its root and immediately works on improving and even reversing many of the symptoms and secondary conditions resulting from this common deformity. These include low arches, overpronation, plantar fasciitis or heel pain, knee pain, hip pain, back pain and many others, both in children and adults.

Foot and ankle surgeons are invited to learn more about the HyProCure^® device and procedure at www.GraMedica.com, where they can also train online and/or find a live surgical training seminar in their area.

Potential surgical candidates, from China and around the world, can find out more about the HyProCure^® solution and the devastating effects of talotarsal dislocation at www.HyProCure.com. Find a local HyProCure^® specialist through the physician locator at http://hyprocure.com/doctor-locator/.

About GraMedica^®:
GraMedica^® is a global orthopedic medical device company and leader in foot care solutions. Recognized for its innovation, the company is producer of breakthrough products like HyProCure^®  and osteo-WEDGE_TM.

Learn more about HyProCure^®  and osteo-WEDGE_TM, GraMedica^®’s latest innovative Bone Locking System at http://www.GraMedica.com; follow updates on http://www.Facebook.com/HyProCure.

Contact:
Susan Doherty, Director, Education & Physician Resources
+1-586-677-9600
sdoherty@grahamiii.com